Two-component systems, composed of an autohistidine kinase and a phosphorylatable response regulator, are widely used in bacterial signal transduction. In Escherichia coli, the response regulator CheY controls the sense of rotation of the flagellar motor by switching between two stable states (CheY and phosphorylated CheY [CheYϳP] ), enabling bacterial chemotaxis. CheYϳP interacts strongly with the flagellar motor switch protein FliM to effect a change in the motor rotational bias from counterclockwise to clockwise. Unphosphorylated CheY also interacts with FliM, though with substantially reduced affinity. Because residues on the FliM binding surface of unphosphorylated CheY (e.g., Tyr 106 ) would sterically block FliM from binding, the structural basis of the moderate affinity of unphosphorylated CheY for FliM remains unclear.
The structures of unphosphorylated, Mg 2ϩ -free CheY (apoCheY) (28) and CheY bound to the BeF 3 Ϫ phosphoryl analog (19) provide evidence that a network of conserved residues enables allosteric communication between the phosphorylation site (Asp 57 ) and the target binding site. Like (4) . The backbone conformation of CheY also changes in response to BeF 3 Ϫ activation, most notably at the ␤4-␣4 and ␤5-␣5 loops on the ␣4-␤5-␣5 surface (19) , where FliM binds (20) .
Dynamic excursions to the active state. There exists a growing body of evidence that the unphosphorylated state of response regulators exists in dynamic equilibrium between inactive (unphosphorylated-like) and active (phosphorylated-like) conformations. Perturbations such as phosphorylation or mutation might then shift this equilibrium to favor the active conformation, giving rise to the notion of equilibrium shift activation (Fig. 1B) . Here we imagine that the inactive conformation is favored in the absence of a ligand. The ligand binds more tightly to the active conformation and drives the equilibrium to favor the active conformation. Since the active and inactive conformations preexist, the idea that a bound ligand is not required to flip the conformational switch is fundamental to the equilibrium shift model. This is in contrast to the induced-fit model, where ligand binding and switching are concomitant (Fig. 1A) . In this case the active conformation cannot be formed until the ligand is bound. It should be noted that although the original formulation of the Y-T coupling model includes no elements of equilibrium shift, the two models (Y-T coupling and equilibrium shift) are not mutually exclusive, as the equilibrating species could be coupled by the Y-T mechanism.
For the CheY homologs Spo0F and NtrC, nuclear magnetic resonance studies have shown that the regions that undergo phosphorylation-induced structural changes also experience dynamic excursions on the millisecond to microsecond time scale, consistent with coordinated conformational fluctuations (9, 27) . In both studies the authors suggested that these fluctuations are due to conformational exchange between inactive and active conformations. These data have been interpreted in the context of a model whereby phosphorylation drives a preexistent equilibrium, rather than inducing a new conformation. There is some evidence that the CheY signaling surface experiences similar slow-time-scale fluctuations (23) , and the concept of equilibrium shift activation was applied to CheY to rationalize the phosphorylation-independent activity of the variant CheY D13K , despite its paradoxically inactive conformation in the crystal (14) . The structure of a related constitutively active mutant, CheY D13K/Y106W (CheY**), was also found in the inactive conformation when not bound to the 16 N-terminal residues of FliM (FliM 16 ), yet this same mutant was able to switch to the active (BeF 3 Ϫ -CheY-like) conformation in complex with FliM 16 (8) . This result indicates that, at least for CheY**, phosphorylation is not necessary for conformational switching, and FliM 16 binding is sufficient to throw the switch to the active conformation, consistent with the equilibrium shift model. Finally, the equilibrium shift model of activation has been used to rationalize the residual activity of unphosphorylated CheY at the flagellar motor (3, 6) .
Intermediate CheY conformations. In the atomic resolution structure of apoCheY (i.e., CheY in the absence of Mg 2ϩ , phosphoryl group, or peptide ligand; Protein Data Bank accession no. 1JBE.pdb), there exist two roughly equally populated conformations of the ␤4-␣4 loop and the Tyr 106 side chain (25) . The authors of that study suggested that these sets of conformations are correlated and that one is the bona fide inactive conformation, which sterically blocks FliM, while the other, "meta-active" conformation is "responsible for the active properties seen in apoCheY" (25) . As the authors point out, this structure does not support the equilibrium shift model, as the meta-active conformation is significantly different from the conformation of BeF 3 Ϫ -CheY. A physiological role for such intermediate species was recently demonstrated by the structures of CheY in complex with CheZ residues 200 to 214 (CheZ C ), in which CheZ C -bound CheY is found in a partially switched conformation (11) .
To more thoroughly map the regions of conformational space accessible to CheY in the absence of phosphorylation, we have solved the X-ray crystal structure of unphosphorylated Mg 2ϩ -bound CheY in complex with a 16-mer peptide corresponding to FliM 16 to 2.4-Å resolution. Analysis of the structure indicates that unphosphorylated CheY accommodates bound FliM 16 without switching to the canonical active conformation yet shares several features of the active conformation, perhaps most notably the complete burial of Tyr 106 . Combined with the observations that a functionally important region (the ␤4-␣4 loop) is stabilized by an interaction network that is unique to this complex, while another region (the ␣1 helix) remains in a distinctly inactive conformation, these results indicate that the energy landscape between the inactive and active conformations of CheY is more complex than previously thought.
Finally, this structure provides a molecular view of how allostery in CheY works in reverse, whereby the binding of FliM is coupled to conformational changes in the active site that affect phosphorylation (24) . Whereas neither the Y-T coupling nor the equilibrium shift model of activation is completely consistent with the details of the CheY-FliM 16 complex, we discuss an alternate allosteric activation model that recognizes a role for the ␤4-␣4 loop in signal propagation.
MATERIALS AND METHODS
Protein purification, crystallization, and data collection. E. coli CheY was overexpressed and purified using a previously described protocol (13) . The FliM peptide (MGDSILSQAEIDALLN) was purchased from Macromolecular Resources (Fort Collins, CO) at 90% purity. The Mg 2ϩ -CheY-FliM complex crystallized in space group P2 1 . To form the complex, a solution of 0.5 mM CheY and 10 mM Tris (pH 7.0) was slowly saturated with solid FliM peptide (ϳ10 mM). Diffraction quality crystals were grown by mixing 3 l of this solution with 3 l of well solution containing 30% polyethylene glycol 6000, 50 mM MES (morpholineethanesulfonic acid), and 50 mM MgCl 2 , at pH 6.0 Crystals were grown in about 8 weeks at 4°C using the hanging-drop method. A single crystal was mounted in a 1-mm silanized glass capillary tube containing a reservoir of well solution to allow for room temperature data collection. Data collection took place at 24°C on an R-AXIS II (Molecular Structure Corporation) with CuK␣ radiation. A total of 149 nonoverlapping degrees of data were collected, with a 1.0°oscillation range and an exposure time of 10 min. Because we did not find suitable cryoconditions, data were collected on two sections of the same crystal to minimize the effects of radiation damage. In the first orientation, 103°were kept. In the second orientation, 46°were kept, giving a total of 149°. Data were processed to 2.4 Å in space group P2 1 with MOSFLM (21) and scaled using SCALA (7) .
Structure determination. Initial phases were determined by molecular replacement using the program EPMR (17) and Protein Data Bank entry 3CHY.pdb (28) , with Tyr 106 modeled as alanine, as the search model. As suggested by the Matthews coefficient, EPMR found a solution with two CheY molecules in the asymmetric unit (R value of 0.36 using data to 3.0 Å). Electron density generated following anisotropic B-factor and bulk solvent correction (used throughout refinement) clearly showed the bound peptide and the buried orientation of the In Ramachandran space, 88.5% of residues are in the favored region, 9.5% are in the allowed region, 1.2% are in the generously allowed region, and 0.8% are in the disallowed region, due to the CheY Asn 62 ␥-turn (28). Data collection and refinement statistics are given in Table 1 .
Structure analysis. Ramachandran statistics were generated using PROCHECK (18) . Molecular images were generated using PyMOL (DeLano Scientific). Data plots were generated in SigmaPlot (Synergy Software, Reading, PA). Leastsquares superposition of various CheY structures onto the structure of unphosphorylated CheY (Protein Data Bank accession no. 3CHY.pdb) (28) was performed using the program LSQKAB (16) , which also calculates individual C␣ displacements and overall root mean square deviation. All C␣ atoms were used to generate the superpositions, with the exception of the nine C-terminal residues (121 to 129) of the BeF 3 Ϫ -CheY-FliM 16 complex, which take on a confor- 
RESULTS
The refined structure contains two unphosphorylated Mg 2ϩ -bound CheY-FliM 16 complexes per asymmetric unit (Protein Data Bank accession no. 2B1J.pdb), which will hereafter be referred to simply as CheY-FliM 16 . Electron density corresponding to residues 2 through 16 of the bound peptides (chains C and D, bound to CheY chains A and B, respectively) is unambiguous, though it is weak at the termini (Fig. 2) 16 (chain C, green) bound to unphosphorylated Mg 2ϩ -CheY (chain A, tan). The displayed electron density is a͉F o ͉ Ϫ ͉f c ͉-simulated annealing omit map generated with chain C omitted in the program CNS. In order to display the weak density at the peptide termini, the map has been contoured at 3.6 around the entire peptide (cyan, fine mesh, residues 2 to 16) and at 2.4 around the peptide termini (purple, coarse mesh, residues 2 to 5, 15, and 16). Fig. 3 and 4) . Structure overview. The FliM peptide is in a conformation similar to that of the previously determined CheY-FliM 16 complexes (8, 20) . Additionally, the Mg 2ϩ binding site is arranged as in previous Mg 2ϩ -CheY structures: the side chain carboxyl oxygens of Asp 13 and Asp 57 , the backbone carbonyl oxygen of Asn 59 , and three water molecules (one of which H bonds to the Asp 12 carboxyl oxygen) form an octahedral coordinate sphere around the bound divalent magnesium ion (4, 19, 20, 26 The two CheY molecules in the asymmetric unit are NCS related yet are not identical; chain B has more "active character" than does chain A, as shown in Fig. 4 . However, because the differences are small (Ͻ1 Å), occur primarily in loop regions, and may arise from different constraints placed on the two complexes within the crystal, they will not discussed in detail here.
Details of the CheY-FliM 16 interface. In complex with Mg 2ϩ -CheY, the conformation of FliM 16 is similar to that observed previously in the BeF 3 Ϫ -CheY-FliM 16 (20) and CheY**-FliM 16 (8) complexes; residues 2 through 7 are in an extended conformation, and residues 8 to 14 form two helical turns. Additionally, the amount of surface area that is buried in the CheY-FliM 16 interface is similar for the three complexes The loss of several previously observed intermolecular contacts in the CheY-FliM 16 interface is consistent with the re- Ϫ activation results in a ϳ3.5-Å shift at the Glu 89 C␣ relative to apoCheY, in chain A of the CheY-FliM 16 complex this position is displaced from its inactive position by ϳ1 Å, while in chain B the shift is larger (ϳ2 Å) though still less than that observed for the BeF 3 Ϫ -CheY-FliM 16 -complex (Fig. 4A) . Additionally, residues 88 to 90 are modeled as two equally populated conformations in both CheY-FliM 16 complexes, largely to accommodate two conformations of the Glu 89 side chain. Therefore, it appears that this loop has a significant degree of conformational freedom in the CheY-FliM 16 complex. Besides being in a position intermediate to the that of apoCheY and BeF 3 Ϫ -CheY, it should be noted that the four loop subconformations we observe (two per CheY) are each distinct from that of metaactive CheY, where the largest displacement (relative to the 1.7-Å apoCheY structure, which did not model static disorder in the ␤4-␣4 loop) are at Ala 90 (Fig. 3B) (B) , and the ␤5-␣5 loop and the ␣1 helix (C). In panel B, the hydrogen bond formed between Gly 89 and Asn 59 (dashed line; chain B, subconformation b) is similar to the association between these residues in the BeF 3 Ϫ -CheY-FliM 16 complex. In panel C, the ␣1 helix of the CheY-FliM 16 complex, which remains in the inactive conformation (see Fig. 3 (Fig. 4A) , at several points during refinement dual conformations of Thr 87 (backbone and side chain) were modeled and subjected to rounds of refinement. However, because these efforts led to increased R free values and no apparent improvement in the quality of the Thr 87 side chain electron density, they were abandoned in favor of a single Thr 87 conformation. We imagine that, similar to the ␤4-␣4 loop, Thr 87 in the CheY-FliM 16 complex has significant conformational freedom, though we cannot rule out the possibility that it takes on two closely spaced static conformations in different unit cells of the crystal (static disorder) which are not resolved. As discussed further in Discussion, the Y-T coupling model would have predicted Thr 87 to be forced to occupy the active conformation due to the complete burial of Tyr 106 in complex with FliM 16 , though this is clearly not the case (Fig. 4A) .
DISCUSSION
Conformational coupling in unphosphorylated CheY. Information flow between the phosphorylation site and the target binding site has been shown to be bidirectional for CheY and other response regulator proteins (1, 24) . The notion that ligands can affect CheY autophosphorylation kinetics by inducing conformational changes at the active site, termed conformational coupling, was hypothesized previously to explain the ability of FliM 16 to accelerate CheY autophosphorylation by nearly 30-fold (24) . The "two-way street" notion of allostery assumes that allosteric communication in both directions (phosphorylation site to the target binding site and vice versa) happens by a flip of the same conformational switch, yet in complex with FliM 16 , unphosphorylated CheY remains in a substantially inactive conformation (11) .
In addition to supporting or refuting allosteric models, this structure provides insight as to the relationship between structure and function (binding, catalysis, etc.) in CheY. In the structure of BeF 3 Ϫ -CheY, the Thr 87 hydroxyl and Ala 88 backbone amide coordinate the BeF 3 Ϫ fluorine atoms that are thought to be analogous to the aspartyl-phosphate phosphoryl oxygens (19 Ϫ -CheY (Fig. 4A ). This repositioning of Thr 87 and Ala 88 in the direction of the phosphoryl-binding site may account for the increased rate of CheY autophosphorylation in the presence of FliM 16 . This structure-function relationship is also supported by structural and biochemical studies of the CheY-CheA P2 complex, which has both a decreased autophosphorylation rate (24) and a significantly increased distance between the Thr 87 side chain and the phosphorylation site (22) relative to CheY alone,. Similarly, when this hydroxyl is made unavailable to the active site by mutation of the Thr 87 side chain to a non-Ser amino acid, the CheY autophosphorylation rate also decreases dramatically (2). In summary, (i) Thr 87 can take on a spectrum of conformations intermediate to the fully active and fully inactive conformations, (ii) allosteric ligands can affect the Thr 87 position, and (iii) the proximity of the Thr 87 hydroxyl to the active site correlates positively with the autophosphorylation rate. These data provide evidence in support of the conformational coupling hypothesis and highlight a role for Thr 87 in this process. The equilibrium shift allosteric model. The equilibrium shift model of activation predicts the structure of unphosphorylated Mg 2ϩ -CheY-FliM 16 to be essentially identical to that of CheYϳP. While a comparison of BeF 3 Ϫ -CheY with the CheYFliM 16 structure clearly indicates that this is not the case, the degree to which these results refute the equilibrium shift model of activation is a matter of perspective. The CheYFliM 16 structure presented shows that in wild-type CheY the network of conserved residues can achieve an active-like arrangement in the absence of phosphorylation, as predicted by the equilibrium shift model. In contrast, phosphorylation appears to be a prerequisite for complete conformational switching of wild-type CheY, especially in regions remote from the target binding site such as the ␣1 helix and the ␤5-␣5 loop (Fig.  3A) . This indicates that, unlike for CheY**, the equilibrium shift model is not sufficient to describe the allosteric activation process for wild-type CheY.
FliM 16 affinity and the two-state assumption. The inability of unphosphorylated CheY to form several stabilizing contacts when bound to FliM 16 (relative to BeF 3 Ϫ -CheY-FliM 16 ) provides a molecular basis for the reduced FliM affinity of unphosphorylated CheY relative to that of CheYϳP. While the equilibrium shift model rests on the simple assumption that the folded protein can access only two stable states, its proponents must invoke preequilibrating subpopulations that are difficult or impossible to detect. Further, it ascribes affinity changes that result from phosphorylation to a shift in the inactive-to-active preequilibrium. Instead, our results suggest that the affinity difference has straightforward structural origins involving polar interactions near the peptide termini and that phosphorylation is in fact a prerequisite for the formation of the high-affinity FliM 16 interface.
The concurrence of active-like (resembling BeF 3 Ϫ -CheY) and inactive-like (resembling apoCheY) features in the same CheY conformation represents a clear though unanticipated (Fig. 4A) , the correlation between the conformations of these two residues does not appear to be exclusive and may involve the influence of another region of the protein.
An alternate model to Y-T coupling that is consistent with the structure presented here would recognize the participation of the ␤4-␣4 loop, in addition to steric occlusion, to explain the conformational correlation between Tyr 106 and Thr 87 . The structures of meta-active CheY (25) , the CheY-CheZ C complex (11) , and the CheY-FliM 16 16 complex is essentially in the active position, yet the C␣-C␤ bond vector is inclined away from the active site as in apoCheY (Fig. 4A and  D) , it appears that the fully active orientation of the ␤4-␣4 loop is related to a twist in the backbone that makes the Thr 87 hydroxyl available to the phosphorylation site. In a past study, the pseudodihedral angle defined by the C␣ atoms of residues 87, 88, 89, and 90 was used to quantify the ␤4-␣4 loop activation state (10) . For unphosphorylated (FliM 16 -free) CheY structures, including meta-active CheY, the value of this pseudodihedral angle is in the range of 10°to 30°, while values of ϳ110°characterize the BeF 3 Ϫ -CheY and BeF 3 Ϫ -CheYFliM 16 structures (Fig. 5A ). In the CheY**-FliM 16 complex, the only instance where complete switching to the active (BeF 3 Ϫ -CheY-like) conformation is achieved in the absence of a phosphoryl analog, the value of the 87:88:89:90 pseudodihedral angle is nearly identical to that of BeF 3 Ϫ -CheY (108°a nd 110°, respectively). Consistent with the intermediate conformations of this loop in the CheY-FliM 16 structure (Fig. 4A) , the values of the 87:88:89:90 pseudodihedral angle for the four observed subconformations (two per CheY) in the structure presented take on a spectrum of values intermediate to those for the canonical active and inactive conformations (Fig. 5A) . The partially activated position of the ␤4-␣4 loop in phosphono-CheY (12) is also evidenced by an intermediate value of the 87:88:89:90 pseudodihedral angle (Fig. 5A) .
By devising metrics for local conformational change and plotting the values of these metrics as pairwise combinations for a family of related structures, one can get a sense of the degree of coupling between two regions of a protein. First, the focus here will be on the ␤4-␣4 loop and its degree of coupling to Tyr 106 and Thr 87 , after which the apparently weak coupling between Tyr 106 and Thr 87 will be revisited in a quantitative manner. Analysis of a number of CheY structures indicates that the solvent-exposed (inactive) rotamer position of Tyr 106 (as measured by the Tyr 106 chi1 dihedral angle) is observed only when the ␤4-␣4 loop is in the inactive conformation but that the buried (active) Tyr 106 rotamer can be found in conjunction with the entire spectrum of possible ␤4-␣4 loop conformations (Fig. 5B) . From the perspective of the loop, the inactive (apoCheY-like) ␤4-␣4 conformation is found in conjunction with both the buried and exposed Tyr 106 conformations, while the active loop conformation is found only when Tyr 106 is buried (Fig. 5B) . From these data it is clear that the conformations of Tyr 106 and the ␤4-␣4 loop are not exclusively coupled, although the combination of Tyr 106 being exposed and ␤4-␣4 being active appears to be forbidden. Note that the combination of Tyr 106 being buried and ␤4-␣4 being inactive, which was reported previously to be sterically discouraged (25) , is occupied by both meta-active CheY and, to a lesser degree, the CheY-FliM 16 complex. There appear to be at least two reasons for this: (i) the pseudodihedral angle defined by the C␣ positions of residues 87, 88, 89, and 90 of meta-active CheY is essentially the same as that of inactive CheY, and (ii) Tyr 106 has some flexibility in the buried conformation and can move slightly to alleviate potential steric clashes with inactivelike conformations of the ␤4-␣4 loop, as observed in the CheYFliM 16 complex. The later observation was also made by the authors of the report on the CheY-CheZ C complex structure, CheY-CheZ C , and even CheY**-FliM 16 , where the indole nitrogen on Trp 106 serves as the proton donor). Therefore, these data encourage use of the term gating to acknowledge the more efficient Tyr 106 gating ability of the active, rather than the inactive, loop conformation (Fig. 5B) , though the two mechanisms are not mutually exclusive. The T-loop-Y model also recognizes the ability of Tyr 106 , when solvent exposed, to gate the ␤4-␣4 loop in the inactive conformation, as is the case when CheY binds to CheA P2 .
Relevance to CheZ C peptide binding. As mentioned previously, the recently published CheY-CheZ C complex (11) also agrees well with this formulation of the T-loop-Y model, since the burial of Tyr 106 by bound CheZ is not sufficient to cause switching of Thr 87 and results in only modest displacement of the ␤4-␣4 loop in the absence of BeF 3 Ϫ . Additionally, in all seven of the CheY-CheZ structures (with and without BeF 3 Ϫ ) and the two substructures, differing degrees of Thr 87 activation correlate with the ␤4-␣4 loop activation state.
In contrast, the structure-function trend that we observe for Thr 87 of CheY complexed with FliM 16 and CheA P2 (positive correlation between the Thr 87 hydroxyl-to-phosphorylation site distance and observed autophosphorylation rate) is not apparent in the CheY-CheZ C complexes. Instead, in the CheY-CheZ C structures that lack BeF 3 Ϫ , Thr 87 retains a distinctly inactive conformation despite biochemical studies that shows CheZ C binding to accelerate CheY phosphorylation kinetics (24) . This may indicate that that the mechanism by which events at the peptide ligand binding surface are conformationally coupled to the active site may be subtly different for different ligands.
In conclusion, the crystallographic CheY-FliM 16 complex demonstrates that the structural changes associated with CheY phosphorylation are not exclusively coupled and in some regions are capable of adopting conformations intermediate to those of the inactive and active states. Additionally, the partially switched conformation that we observe for the crystalline CheY-FliM 16 complex agrees well with the nuclear magnetic resonance peak positions of this complex, which are typically intermediate to those of inactive CheY (apo or Mg 2ϩ -bound) and active (BeF 3 Ϫ -bound) forms of CheY (C. M. Dyer and F. W. Dahlquist, unpublished observations). In light of these results, it is clear that neither the equilibrium shift model, the Y-T coupling model, nor the two-state assumption upon which both models are based is a fully valid descriptor of allostery in CheY. Rather, the T-loop-Y model, which was anticipated on the basis of recent molecular dynamics simulations and acknowledges the active role of the ␤4-␣4 loop in allosteric signaling (10) , seems more consistent with the experimental results.
